Cassava Sciences | L'Utile Operativo



Operating Profit Cambiamento Data
Abbott USD 1.66B 253M 2025-03
Amgen USD 1.29B 1.02B 2025-03
Biogen USD 311.2M 130.2M 2025-03
Cassava Sciences USD -29487000 1.14M 2024-12
Eisai JPY 27.56B 13.14B 2024-12
Eli Lilly USD 5.41B 259.6M 2025-03
Geron USD -21757000 6.46M 2024-12
J&J USD 13.63B 9.74B 2025-03
Merck USD 5.87B 1.57B 2025-03
Novartis USD 2.28B 1.34B 2024-12
Pfizer USD 3.67B 4.08B 2025-03
Roche Holding CHF 4.39B 1.04B 2024-12



Cassava Sciences L'Utile Operativo - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.